AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 OCT 2 - (NewsRx.com & NewsRx.net) -- Women who choose hormone therapy to treat symptoms of menopause should use the lowest dose for the shortest amount of time, says the U.S. Food and Drug Administration (FDA).
That's the theme of the agency's new campaign that aims to help women confused by news about the risks of long-term hormone use, even as hormones remain a mainstay for treating hot flashes.
In 2002, a major study concluded that long-term use of the hormones estrogen and progestin is more dangerous than once thought. The pills significantly increased a woman's risk of a heart attack or stroke beginning in the first year of use, and increased the risk of breast cancer after 4 years of use.
But hormone therapy does have some benefits. It's considered the most effective treatment for hot flashes, night sweats, and vaginal dryness. It's also one option to prevent bone-thinning osteoporosis.
So who should try ...
Source: HighBeam Research, FDA campaign aims to educate women on HRT.